Medical/Pharmaceuticals
Nippon Express Group's MD Logistics Opens "Garner 2000 Pharmaceutical Logistics Center" in North Carolina, U.S.
TOKYO, April 21, 2023 /PRNewswire/ -- MD Logistics, LLC (hereinafter "MD"), a group company of NIPPON EXPRESS HOLDINGS, INC., held an opening ceremony on March 23 for the Garner 2000 Pharmaceutical Logistics Center, a dedicated pharmaceutical warehouse established inGarner in the U.S. state of Nor...
2023-04-21 14:00
3319
Jim Lim joins Zühlke Group as Head of Health & Medtech in Singapore
SINGAPORE, April 21, 2023 /PRNewswire/ -- Zühlke Group is pleased to announce the appointment ofJim Lim as Head of Market Unit (Health & Medtech) at Zühlke Asia. Based in Singapore, Jim will lead the organisation's regional efforts to serve the healthcare industry and continue to expand Zühlke's ...
2023-04-21 09:13
3176
LTS expands into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business
ANDERNACH, Germany, April 21, 2023 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS"), Oral Thin Films ("OTF") and Micro Array Patches ("MAP") anno...
2023-04-21 00:00
2541
BioMed Technology Funded by Alibaba Hong Kong Entrepreneurs Fund, Gobi and TIMC to Realise Precision and Personalised Gut Microbiome Management for Wellness
HONG KONG, April 20, 2023 /PRNewswire/ -- BioMed Technology Holdings Limited (BioMed),Hong Kong's leading microbiome startup, has raised USD 2 million in its latest oversubscribed seed round from Alibaba Hong Kong Entrepreneurs Fund (AEF), Gobi Partners GBA and The International Medical Co. Ltd. ...
2023-04-20 16:15
4495
Innovent Announces Overall Survival Results of Phase 2 Study of Pemazyre® (pemigatinib) in Chinese Patients with Advanced Cholangiocarcinoma Presented at AACR Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, April 20, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...
2023-04-20 08:00
4062
University of Technology Sydney researchers develop ground-breaking heart failure treatment using 3D-printed heart tissue
New technology enables 'patches' of 3D printed tissue to be applied onto the surface of damaged hearts as a safer and more cost-effective alternative to heart transplants. SYDNEY, April 20, 2023 /PRNewswire/ -- Researchers from The University of Technology Sydney (UTS) have demonstrated that 3D ...
2023-04-20 06:00
2941
uLab® Launches the Orthodontics Industry's First Suite of Practice-Branded Packaging Options
MEMPHIS, Tenn., April 19, 2023 /PRNewswire/ -- uLab Systems™, the creator of the uSmile™ clear aligner platform and the new uAssist™ concierge service, announces it now offers orthodontists a suite of branding options that give them the ability to create a variety of custom-designed packaging pro...
2023-04-19 21:11
3487
Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line
SAN DIEGO, April 19, 2023 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that the United States Food and Drug Administration (FDA) has approved the company's high pot...
2023-04-19 20:05
1953
Lambda Therapeutics partners with Medidata to automate and streamline data management processes for greater clinical trial efficiency
Unified technology platform from Medidata to help Lambda Therapeutics leverage centralized data to address the research process fromend to end NEW DELHI, April 19, 2023 /PRNewswire/ -- Medidata, a Dassault Systèmes company, announced that Lambda Therapeutics is implementing Medidata's cloud-base...
2023-04-19 14:00
2538
HOYA Group PENTAX Medical Singapore Pte. Ltd. Wins the Endoscopy Product Innovation of the Year Award at the Healthcare Asia Medtech Awards 2023
TOKYO, April 19, 2023 /PRNewswire/ -- HOYA Group, PENTAX Medical's Asia Pacific Region Headquarters PENTAX Medical Singapore Pte Ltd has been recognized for its groundbreaking PENTAX Medical INSPIRATM Video Processor with a prestigious Endoscopy Product Innovation of the Year at the Healthcare As...
2023-04-19 11:00
2515
Everest Medicines Announces Strategic Partnership with Shanghai Pharma Subsidiary to Accelerate the Commercialization of XERAVA in Mainland China
SHANGHAI, April 19, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that it has signed a Memorandum of Understandin...
2023-04-19 08:12
2691
Agilis Robotics conducts first live animal trial for GI indication, targeting 510(k) clearance by 2025 to transform endoscopic surgery
HONG KONG, April 19, 2023 /PRNewswire/ -- Agilis Robotics, an innovative spin-off company from TheUniversity of Hong Kong, is making waves in the realm of endoscopic surgery with its flexible robotic arms. Their creation showcases highly miniaturized and flexible endoscopic surgical robotic arms,...
2023-04-19 07:00
3044
Biosyngen announces FDA IND approval of its second product for EBV-positive lymphoma
GUANGZHOU, China, April 18, 2023 /PRNewswire/ -- April 15, 2023, Biosyngen Pte Ltd (hereinafter as "Biosyngen") announced that the Company received IND approval for its second product in the pipeline, a T-cell redirection therapy for the treatment of EBV-positive lymphoma. A week prior to this, t...
2023-04-18 19:03
3491
YS Biopharma Announces Record Vaccine Revenues and Preliminary Financial Results for FY2023 Ended March 31, 2023
FY2023 Revenues Increased by Approximately 30% Year Over Year GAITHERSBURG, Md., April 18, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new ...
2023-04-18 19:00
2424
Daewoong Pharmaceutical and Sygnature Discovery announce drug discovery research collaboration
- 'Daewoong Pharmaceutical enters research collaboration to discover a novel small molecule to target autoimmune diseases using fragment-based drug discovery and virtual high throughput screening SEOUL, South Korea and NOTTINGHAM, England, April 18, 2023 /PRNewswire/ -- Daewoong Pharmaceuti...
2023-04-18 17:16
2737
Illumina Singapore continues to climb in Best Employers Award Reaching 7th Overall
Illumina is celebrating 25 years of global operations and 15 years in Singapore this April. SINGAPORE, April 18, 2023 /PRNewswire/ -- Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) was honoured today to be ranked 7th overall from 250 companies and 1st in Healthcare Equipment & Ser...
2023-04-18 12:41
2527
West Korea Announces Ready Pack™ Containment Solution Extension at COPHEX 2023
SEOUL, South Korea, April 18, 2023 /PRNewswire/ -- West
2023-04-18 10:00
2063
Innovent Releases Final Analysis Results of ORIENT-16: the Phase 3 Study of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric Cancer at the AACR Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, April 18, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...
2023-04-18 08:00
2748
Ocedurenone: A Novel Therapy for Uncontrolled Hypertension in Advanced Chronic Kidney Disease
PRINCETON, N.J., April 18, 2023 /PRNewswire/ -- EMJ Nephrology interviewed two World-renowned experts in nephrology and cardiology,George Bakris and Faiez Zannad, regarding the challenges of treating uncontrolled hypertension (uHTN) in patients with advanced chronic kidney disease (CKD), a large ...
2023-04-18 08:00
2152
Innovent Announces Updated Data of Phase 1 Clinical Trial for IBI351 (KRAS[G12C] Inhibitor) as Monotherapy for Solid Tumors at the AACR Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, April 18, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmolog...
2023-04-18 08:00
2904
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 296 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Announcement of "Cyber Sousa Award" Winners of the 16th Xiamen International Animation Festival
[Picked up by 272 media titles]
2024-11-26 16:48
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
12324
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
8375
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
8090
MMA SMARTIES Thailand 2024 - Celebrates Unparalleled Marketing Innovation and Excellence in Thailand
2024-11-23 11:00
7519
WeBank Powers Fusion Bank's Rapid Launch of a Next-Generation Core Banking System
2024-11-22 15:21
5841